Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury

  • Keelan, Jeffrey (Chief Investigator)
  • Olson, Dave (Investigator 02)
  • Robertson, Sarah (Investigator 03)
  • Kemp, Matthew (Investigator 04)
  • Ellery, Stacey (Investigator 05)

Project Details

StatusActive
Effective start/end date1/01/1831/12/22

Funding

  • National Health & Medical Research Council NHMRC: AUD484,516.00
  • National Health & Medical Research Council NHMRC: AUD400,077.00
  • National Health & Medical Research Council NHMRC: AUD314,339.00
  • National Health & Medical Research Council NHMRC: AUD178,896.00